A Phase I Clinical Study Study of the Safety, Tolerability, and Pharmacokinetics of HX-1171 in Healthy Male Subjects
NCT01548391
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
HX-1171
Sponsor
Biotoxtech Co., Ltd